Given the patient's use of terfenadine and their condition of atopic dermatitis, what is the most likely progression of symptoms if the patient experiences a drug interaction that affects CYP3A4 metabolism?
Increased risk of cardiac arrhythmias due to elevated terfenadine levels Increased frequency of asthma attacks due to reduced efficacy of fluticasone Exacerbation of atopic dermatitis symptoms due to immune dysregulation Hypertensive crisis due to interaction with epinephrine auto-injector